Biocardia, Inc. annual report, Q2 FY1997

Business Context and Reporting Period

Company: NAM Corporation (Note: Input metadata referenced "Biocardia, Inc." but the filing text identifies the issuer as NAM Corporation).

Reporting Period: Fiscal year ended June 30, 1997.

Business Overview: NAM Corporation provides Alternative Dispute Resolution (ADR) services, including arbitration and mediation, primarily to insurance companies, law firms, and self-insured corporations. The company operates offices in New York, Pennsylvania, Massachusetts, South Carolina, Tennessee, and Wisconsin. It maintains a roster of over 900 hearing officers, many of whom are retired judges.

Key Financial Metrics

Metric Fiscal 1997 Fiscal 1996
Net Revenues $3,377,062 $3,147,886
Net Income (Loss) ($637,557) $135,599
Operating Margin -19.3% 6.5%
Cost of Services Margin 25.3% 23.1%
Working Capital $3,853,430 ($464,426)
Cash and Cash Equivalents $175,486 $31,474
Marketable Securities $3,792,381 $0
Debt (Notes Payable) $0 $400,000

Material Changes vs. Prior Period

  • Revenue Growth: Revenues increased 7% to $3.38 million, driven by higher business volume in existing and new offices, excluding the Pennsylvania office which saw a decline.
  • Profitability Shift: The company swung from a net income of $135,599 in 1996 to a net loss of $637,557 in 1997. This was primarily due to a 138% increase in General and Administrative (G&A) expenses and non-recurring IPO-related charges.
  • Expense Reclassification: A significant portion of the G&A increase ($609,000) was due to reclassifying executive and administrative salaries from "Sales and Marketing" to "G&A" to better reflect organizational restructuring. Without this reclassification, G&A would have appeared lower, and Sales and Marketing higher.
  • Liquidity Transformation: Working capital improved from a deficit of $464,426 to a surplus of $3.85 million following an Initial Public Offering (IPO) in November 1996 that raised net proceeds of $4.7 million.
  • Debt Repayment: The company repaid $400,000 in private placement notes using IPO proceeds, eliminating its short-term debt.

Guidance, Outlook, and Risks

  • Expansion Strategy: Management plans to open new offices in regions without current presence and pursue acquisitions to consolidate the fragmented ADR market. A new Midwest region (Wisconsin/Illinois) was established in late fiscal 1997.
  • Marketing Investment: The company intends to launch a large-scale advertising campaign in fiscal 1998 to increase national awareness beyond the insurance market.
  • Technology: Plans are underway to introduce on-line case management software and enhanced internet services for clients during fiscal 1998.
  • Risks:
    • Profitability of New Offices: New offices may incur net losses in the short term as they mature. Past experience (e.g., a closed Minnesota office) indicates no assurance of future profitability.
    • Competition: The ADR industry is highly competitive with low barriers to entry. Competitors include the American Arbitration Association and JAMS.
    • Customer Concentration: One insurance company customer represented approximately 14% of total revenues in 1997.
    • Market Conditions: Changes in the public court system or insurance industry could materially affect demand for ADR services.
  • Unusual Items: The 1997 loss included $115,500 in costs incurred for the benefit of selling shareholders and expenses related to the IPO. The 1996 results included a $61,127 write-off of deferred offering costs from an abandoned 1995 IPO attempt.

Investor Verification Checklist

  • Expense Reclassification Impact: Verify the sustainability of the reported expense structure given the significant shift of salaries from Sales/Marketing to G&A in 1997.
  • New Office Performance: Monitor the profitability timeline for the new Wisconsin/Midwest office and the turnaround efforts in the Pennsylvania office.
  • Customer Concentration: Assess the risk associated with the single insurance client representing 14% of revenue and the stability of that relationship.
  • Capital Deployment: Track the utilization of the $3.7 million in invested marketable securities and the effectiveness of the planned fiscal 1998 advertising campaign.
  • Stock-Based Compensation: Review the pro forma impact of stock options on future earnings, as the company currently uses APB No. 25 rather than SFAS No. 123 fair value accounting.